Dr. Khan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661- Is this information wrong?
Summary
- I currently serve as an Assistant Professor of Medicine and the Director of Myeloma Epidemiology Research at the University of Texas Southwestern Medical Center. I'm a graduate of the University of Michigan Medical School, Harvard T.H Chan School of Public Health, and Columbia Mailman School of Public Health. I completed residency in Internal Medicine at the Cleveland Clinic & Lerner College of Medicine and a fellowship in hematology/oncology at Beth Israel Deaconess Medical Center & Harvard Medical School. I have been a hospitalist at Massachusetts General Hospital as well as an instructor at Harvard Medical School. I practice and conduct research as a hemoncologist and epidemiologist focusing on myeloma/plasma cell dyscrasias, cancer epidemiology, and general medicine/public health.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
Columbia University Mailman School of Public HealthMS, Executive Program in Epidemiology, 2017 - 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2017
University of Michigan Medical SchoolClass of 2014- Harvard T. H. Chan School of Public HealthMPH, Quantitative Methods, 2012 - 2013
- University of OklahomaBA, Mathematics, Psychology, 2003 - 2007
Certifications & Licensure
TX State Medical License 2022 - 2025
MA State Medical License 2017 - 2025
OH State Medical License 2014 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Facing inadequacies: cultivating compassion from past failures.Adeel M Khan> ;The Lancet. Oncology. 2021 Jun 1
- 1 citationsSurvival outcomes with warfarin compared with direct oral anticoagulants in cancer-associated venous thromboembolism in the United States: A population-based cohort st...Adeel M Khan, Thita Chiasakul, Robert Redd, Rushad Patell, Ellen P McCarthy, Donna Neuberg, Jeffrey I Zwicker> ;Plos Medicine. 2022 May 1
- A Cancer by Any Other Name.Adeel M Khan> ;The Oncologist. 2021 Oct 1
- Join now to see all
Journal Articles
- A Cancer by Any Other NameKhan AM, The Oncologist, 10/9/2021
Press Mentions
Cancer-Causing Chemical Was Found in These Diabetes Medications: Merck Says They Can Fix ItJanuary 20th, 2023
Hospital Affiliations
University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
